@inproceedings{inproceedings, title  = {{Abstract OT1-04-05: A phase 2 randomized, double-blind, placebo-controlled trial of radium-223 dichloride with exemestane and everolimus in patients with HER2-negative, hormone receptor–positive breast cancer and bone metastases}},

 publisher = {{American Association for Cancer Research}},

 url = {{}},

 year = {{2017}},

 month = {{2}},

 author = {{Rugo HS and Drumea KC and Campone M and Barnadas A and Petrenciuc O and Zhang A and Li R and Coleman RE}},

 doi = {{10.1158/1538-7445.sabcs16-ot1-04-05}},

 journal = {{Ongoing Clinical Trials}},

 note = {{Accessed on 2025/10/10}}}